Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 12, 2026 08:00 ET | Source: Oryzon Genomics, S.A.

ORYZON Expands Patent Protection for Iadademstat with Grant Decision in Mexico Covering Combinations with PD-1/PD-L1 Inhibitors

Key combination for the treatment of Small Cell Lung Cancer MADRID and CAMBRIDGE, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage...
March 10, 2026 19:25 ET | Source: Metalcloak (Armored Works, LLC)

MetalCloak Advances Off-Road Suspension with Expanded RockSport BLACK Line

Rancho Cordova, CA, March 10, 2026 (GLOBE NEWSWIRE) -- MetalCloak, the industry leader in high-performance suspension systems and precision off-road engineering, today announced the continued...
March 10, 2026 09:55 ET | Source: Templafy Limited

Templafy erhält Patent für Technologien zur Dokumentenerstellung

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Templafy, die führende KI-gestützte Plattform zur Dokumentenerstellung, die es Fachleuten ermöglicht, mit höchster Effizienz präzise, richtlinienkonforme...
March 10, 2026 09:55 ET | Source: Templafy Limited

Templafy obtient un brevet pour ses technologies de génération de documents

NEW YORK, 10 mars 2026 (GLOBE NEWSWIRE) -- Templafy, la principale plateforme de génération de documents alimentée par l’IA qui permet aux professionnels de créer des documents précis, conformes et...
March 10, 2026 08:59 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease

Innovative non-hallucinogenic treatment combines MEAI with Palmitoylethanolamide to address obesity and metabolic dysfunction-associated steatotic liver disease, tapping into a rapidly growing market...
March 10, 2026 08:16 ET | Source: Templafy Limited

Templafy Issued Patent for Document Generation Technologies

Templafy, the leading AI-powered document generation platform for professionals, announces the company’s first patent for document generation technologies.
March 09, 2026 08:00 ET | Source: Renewal Fuels, Inc.

Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Appoints Andrew S. Mikulski as Independent Director and Provides Patent Portfolio Update for Texatron Fusion Platform

Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Appoints Andrew S. Mikulski as Independent Director
March 05, 2026 08:30 ET | Source: CDT Equity Inc.

CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent
March 05, 2026 08:00 ET | Source: Starton Therapeutics Inc.

Starton Therapeutics Files Patent Applications for the Use of CAR-T Cell Therapies in Combination with its Proprietary, Continuous Low-Dose Immunomodulatory Therapy, STAR-LLD, a formulation of Lenalidomide, for the Treatment of Blood Cancer

The potential of STAR-LLD to improve lenalidomide’s therapeutic index suggests an opportunity for use in combination with CAR-T cell therapies.As described in the patent application, STAR-LLD's...
March 04, 2026 10:01 ET | Source: LITXCHANGE

LitXchange Files Patent for Blockchain-Anchored Trade Verification Across Stocks and Crypto

Rockwall, TX, March 04, 2026 (GLOBE NEWSWIRE) -- LitXchange, a fintech infrastructure company building a next-generation stock and crypto trading platform, announced today that it has filed a patent...